Revenue
$501.4m
+134.2% ↑ vs $214.1m
Catastrophic claims and reserve strengthening obscured a stronger underlying book and prompted Tower to skip the interim dividend.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
HY23 vs HY22
Revenue
$501.4m
+134.2% ↑ vs $214.1m
Net profit after tax
−$5.1m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net cash inflow from operating activities
$18.2m
-27.5% ↓ vs $25.1m
Declared dividend per share
—
— vs 2.5c
Profit before tax
−$8.3m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Total assets
$1.1b
+39.4% ↑ vs $762.5m
What changed
Underlying loss including large events was $3.3m versus a $5.4m profit in HY22, and the reported result also reflects strengthening of residual prior-period claims reserves.
The balance sheet expanded materially. Total assets reached $1.1b versus $762.5m, an unprecedented level against Annolyse's historical baseline mean of $675.8m, with total liabilities up 68.4% to $767.0m and equity down 3.7% to $295.6m. Operating cash inflow was $18.2m versus $25.1m. Tower did not declare an interim dividend (HY22 paid 2.5c per share). The Papua New Guinea subsidiary sale and Suva building disposal were classified as discontinued operations, contributing $2.3m after tax.
What matters
Underlying NPAT excluding large events rose from $18.2m to $23.6m, supported by premium-rate increases, underwriting changes and expense control. The $5.1m reported loss reflects catastrophic claims and reserve strengthening rather than premium-rate or expense issues, which means this is a claims-volatility story rather than a structural margin story.
The skipped interim dividend changes the capital-return signal. HY22 paid a 2.5c interim, and total FY22 dividends were 6.5c. The release uses "prudent" language without specifying when interim distributions resume, so the shareholder cash-return profile is materially less visible than at HY22.
Balance-sheet expansion outpaces business growth on any reasonable basis. Liabilities rose 68.4% while equity slipped 3.7%, suggesting outstanding claims liabilities and offsetting reinsurance recoveries have both inflated. For an insurer this raises questions about solvency margin and reinsurance counterparty exposure that the supplied excerpts do not directly answer.
Expectations
Management has flagged the Auckland storm of 9 May as expected to be a large event of $4m to $6m, which will land in H2. Annolyse's historical baseline shows HY normally represents 48.5% of full-year revenue and only 15.6% of full-year NPAT, so the business is structurally second-half-weighted; on that pattern an H2 carrying further catastrophe costs becomes unusually sensitive to weather frequency. The supplied materials do not provide an updated FY23 underlying NPAT range, so the gap between the strengthened ex-events run-rate and any full-year landing point is not directly bridgeable from this release.
Quality of result
The $5.4m uplift in ex-large-events underlying NPAT is consistent with the commentary on rate increases and expense control, and revenue grew across the New Zealand segment ($217.5m vs $189.6m), which supports a real core-book improvement rather than a presentation effect.
Two items reduce confidence in the reported number. Reserve strengthening on residual prior-period claims is a balance-sheet judgement that has weakened P&L without a clear forward-looking driver in the supplied text, so it could recur. The effective tax rate of 10.3% is unprecedented low versus a historical baseline mean of 35.3%, and on a near-break-even pre-tax position that distortion swings the optics; PBT (a loss of $8.3m vs $5.6m profit) is the cleaner read on operating performance. Headline revenue is shown rising materially, but Annolyse's historical baseline flags this as a basis discontinuity rather than a comparable trend, which means top-line growth should not be treated as a like-for-like signal. Cash conversion fell but is less decision-relevant for an insurer than claims and solvency.
Unresolved
This briefing cannot assess Tower's regulatory solvency position, reinsurance recoverability, or detailed claims-cohort development from the supplied materials.
Chat
Ask follow-up questions about Tower's HY23 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
Tower HY23 Financial Statements (including auditor's report)
HY23 / financial reportTower HY23 Media Release
HY23 / media releaseTower HY23 Results Announcement
HY23 / results announcementTower HY23 Results Announcement Presentation
HY23 / results presentationTower HY22 Investor Presentation
HY22 / results presentationTower HY22 Results Announcement
HY22 / results announcementTower HY22 Results Release
HY22 / results releaseTower HY22 Signed Financial Statements
HY22 / financial reportTower FY22 Financial Statements (including auditor's report)
FY22 / financial reportTower FY22 Investor Presentation
FY22 / results presentationTower FY22 Results Announcement
FY22 / results announcementTower FY22 Results Announcement Script
FY22 / results releaseTower Limited - Annual Meeting Address
HY22 / commentaryAnnual Meeting Address
HY23 / commentaryTower Updates Guidance, Provides Update on Large Events
HY23 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Get the next Tower briefing and related NZX reporting-season updates by email.